These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15193556)

  • 1. Virulence and disease in leishmaniasis: what is relevant for the patient?
    Rivas L; Moreno J; Cañavate C; Alvar J
    Trends Parasitol; 2004 Jul; 20(7):297-301. PubMed ID: 15193556
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
    Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunopathogenesis of Leishmania infections].
    Yurdakul P
    Mikrobiyol Bul; 2005 Jul; 39(3):363-81. PubMed ID: 16358498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent infections that rise the HIV viral load.
    Bentwich Z
    J HIV Ther; 2003 Aug; 8(3):72-5. PubMed ID: 12951545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Leishmaniases: parasitic diseases of the immune system?].
    Shuĭkina EE
    Med Parazitol (Mosk); 1980; 49(6):16-22. PubMed ID: 7010105
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current problems of the study and prevention of leishmaniasis].
    Saf'ianova VM
    Med Parazitol (Mosk); 1984; (2):45-51. PubMed ID: 6374406
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection.
    Sindermann H; Engel KR; Fischer C; Bommer W;
    Clin Infect Dis; 2004 Nov; 39(10):1520-3. PubMed ID: 15546090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the antigenic properties and virulence of Leishmania clones (Trypanosomatidae, Leishmania)].
    Emel'ianova LP; Saf'ianova VM
    Parazitologiia; 1982; 16(6):445-51. PubMed ID: 7155626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania/HIV co-infections in the second decade.
    Cruz I; Nieto J; Moreno J; Cañavate C; Desjeux P; Alvar J
    Indian J Med Res; 2006 Mar; 123(3):357-88. PubMed ID: 16778317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional paradox in host-pathogen interaction dictates the fate of parasites.
    Dey R; Khan S; Pahari S; Srivastava N; Jadhav M; Saha B
    Future Microbiol; 2007 Aug; 2(4):425-37. PubMed ID: 17683278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis.
    Pereira BA; Alves CR
    Vet Parasitol; 2008 Dec; 158(4):239-55. PubMed ID: 18922635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania proteins derived from recombinant DNA: current status and next steps.
    Kubar J; Fragaki K
    Trends Parasitol; 2006 Mar; 22(3):111-6. PubMed ID: 16446114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subversion of host cell signalling by the protozoan parasite Leishmania.
    Gregory DJ; Olivier M
    Parasitology; 2005; 130 Suppl():S27-35. PubMed ID: 16281989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intensified virulence of the causative agent in the process of the formation of a focus of cutaneous leishmaniasis].
    Ni GV
    Parazitologiia; 1982; 16(6):452-6. PubMed ID: 6218466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenic features of the genus Leishmania].
    Rodríguez T
    Enferm Infecc Microbiol Clin; 1993 Mar; 11(3):117-9. PubMed ID: 8499508
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.
    Ouaissi A; Ouaissi M
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):102-14. PubMed ID: 15928579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetics of Leishmania virulence.
    Bifeld E; Clos J
    Med Microbiol Immunol; 2015 Dec; 204(6):619-34. PubMed ID: 26047933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.
    Antinori S; Calattini S; Longhi E; Bestetti G; Piolini R; Magni C; Orlando G; Gramiccia M; Acquaviva V; Foschi A; Corvasce S; Colomba C; Titone L; Parravicini C; Cascio A; Corbellino M
    Clin Infect Dis; 2007 Jun; 44(12):1602-10. PubMed ID: 17516404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gingival ulcers as first manifestation of leishmaniasis and HIV infection.
    Montineri A; La Rosa R; Larocca L; Brisolese V; Brancati G; Fatuzzo F; Nigro L
    AIDS; 2008 Jan; 22(1):160-1. PubMed ID: 18090409
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship between leishmaniasis and AIDS: the second 10 years.
    Alvar J; Aparicio P; Aseffa A; Den Boer M; Cañavate C; Dedet JP; Gradoni L; Ter Horst R; López-Vélez R; Moreno J
    Clin Microbiol Rev; 2008 Apr; 21(2):334-59, table of contents. PubMed ID: 18400800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.